Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity

This publication has 39 references indexed in Scilit:

• Clinical Trials in ALS: An Overview
  Seminars in Neurology, 2001
• Partial Prevention of Cisplatin-Induced Neuropathy by Electroporation-Mediated Nonviral Gene Transfer
  Human Gene Therapy, 2001
• Effect of Recombinant Human Nerve Growth Factor on Cisplatin Neurotoxicity in Rats
  Experimental Neurology, 1999
• Is lithium able to reverse neurological damage induced by vinca alkaloids?
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
• A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian Cancer
  Gynecologic Oncology, 1997
• Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum
  Behavioural Brain Research, 1997
• Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy
  Annals of Neurology, 1995
• Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P
  Journal of Neuroscience Research, 1995
• The role of glutathione in combination with cisplatin in the treatment of ovarian cancer
  Cancer Treatment Reviews, 1991
• Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer
  New England Journal of Medicine, 1990